WARNING FOR CONUSMERS: The FDA has recalled certain Medtronic MiniMed insulin pumps because there’s a risk of them being hacked.
Medtronic can't update the MiniMed 508 and Paradigm insulin pumps well enough with any software or patch to address the devices' risks, the FDA says.
Medtronic has identified 4,000 patients in the United States who could be using the recalled insulin pumps that are vulnerable to this issue. The company is working with its distributors to identify other patients who might be using these pumps. Medtronic is giving patients other insulin pumps that have better cybersecurity, and the company sent a letter to them explaining the issue.
"The FDA urges manufacturers everywhere to remain vigilant about their medical products -- to monitor and assess cybersecurity vulnerability risk, and to be proactive about disclosing vulnerabilities and mitigations to address them," Schwartz said. In March, the FDA warned about cybersecurity risks in Medtronic's implantable cardiac devices and telemetry systems.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Medtronic recalls MiniMed insulin pumps as FDA warns about hacking riskThe US Food and Drug Administration issued a warning on Thursday about possible risk of hacking for some diabetes patients' insulin pumps. Certain insulin pumps from Medtronic MiniMed have been recalled due to potential cybersecurity risks.
Read more »
Medtronic recalls some insulin pumps as FDA warns they can be hackedMiniMed 508 Medtronic insulin pumps have cybersecurity problems that can't be updated or patched, and the company is recalling them as a result, the Food and Drug Administration said Thursday.
Read more »
Judge throws the book at a clinic offering unproven stem cell ‘treatments’In what may be the harshest enforcement order yet against a clinic pitching unproven and potentially harmful stem cell “treatments,” a federal judge has ordered a stem cell firm to cease offering the treatments. Columnist hiltzikm explains:
Read more »
FDA approves expanded label for Regeneron/Sanofi's DupixentThe U.S. Food and Drug Administration on Wednesday approved Regeneron Pharmaceut...
Read more »
FDA Tests Find Toxic Chemicals in FoodThe FDA -- for the first time -- has tested food on grocery store shelves for toxic grease and stain-repelling chemicals called PFASs that are known to stick around in the body and the environment for long periods of time.
Read more »
Former FDA Commissioner Scott Gottlieb joins Pfizer's board of directorsScott Gottlieb, who stepped down as Food and Drug Administration Commissioner in April, will join Pfizer's board of directors, the company announced Thursday.
Read more »